Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
BIO International 2018 in Boston June 4-7. I see Zenith on the schedule.
http://convention.bio.org/uploadedFiles/BIO2018_SampleAttendeeList.pdf